These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards. Jenke D PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176 [TBL] [Abstract][Full Text] [Related]
43. Risk-based Strategy to Determine Testing Requirement for the Removal of Residual Process Reagents as Process-related Impurities in Bioprocesses. Qiu J; Li K; Miller K; Raghani A PDA J Pharm Sci Technol; 2015; 69(3):334-45. PubMed ID: 26048741 [TBL] [Abstract][Full Text] [Related]
44. Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2. Gromek K; Hawkins W; Bernier T; Sehner C; Zeller E; Schwind M; Pfister T; Kohan M; Osadolor O; Glogovac M; Tuschl G; Dolan DG; Lovsin Barle E Regul Toxicol Pharmacol; 2020 Aug; 115():104692. PubMed ID: 32522580 [TBL] [Abstract][Full Text] [Related]
45. Aseptic process monitoring--a better strategy. Validation Group, Inc. Wilson JD PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699 [No Abstract] [Full Text] [Related]
46. Cleaning characterization of protein drug products using UV-vis spectroscopy. Rathore N; Qi W; Ji W Biotechnol Prog; 2008; 24(3):684-90. PubMed ID: 18426244 [TBL] [Abstract][Full Text] [Related]
47. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016. Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394 [TBL] [Abstract][Full Text] [Related]
48. Exposure assessment of pharmaceutical powders based on an environmental monitoring method: a pilot study. Demircan Yildirim F; Ekmekci I Med Pr; 2020 Dec; 71(6):649-663. PubMed ID: 33107497 [TBL] [Abstract][Full Text] [Related]
49. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
50. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products. Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108 [TBL] [Abstract][Full Text] [Related]
51. Campaign manufacturing of highly active or sensitizing drugs: a comparison between the GMPs of various Regulatory Agencies. Petrelli F; Scuri S; Grappasonni I; Nguyen CTT; Cocchini A; Magrini E; Caraffa A Clin Ter; 2020; 170(1):e66-e73. PubMed ID: 31850487 [TBL] [Abstract][Full Text] [Related]
52. Investigation of an alternative approach for real-time cleaning verification in the pharmaceutical industry. Sarwar A; McSweeney C; Smith M; Timmermans J; Moore E Analyst; 2020 Nov; 145(22):7429-7436. PubMed ID: 32955041 [TBL] [Abstract][Full Text] [Related]
53. A harmonization effort for acceptable daily exposure derivation - Considerations for application of adjustment factors. Sussman RG; Naumann BD; Pfister T; Sehner C; Seaman C; Weideman PA Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S57-66. PubMed ID: 27221789 [TBL] [Abstract][Full Text] [Related]
54. Fidelity to Science & Correct Scientific Vocabulary-Microbial Control Versus Contamination Control. Tidswell EC; Tirumalai R; Hussong D PDA J Pharm Sci Technol; 2019; 73(5):510-516. PubMed ID: 31101705 [TBL] [Abstract][Full Text] [Related]
55. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing. Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539 [TBL] [Abstract][Full Text] [Related]
56. Managing the microbiological quality of pharmaceutical excipients. Cundell AM PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425 [TBL] [Abstract][Full Text] [Related]